Jim Miller joins C2 Pharma advisory board

Jim Miller joins C2 Pharma's advisory board.

Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, C2 Pharma, has expanded its advisory board with a new member.

Miller is regarded as a biopharmaceutical contract manufacturing and development sector expert and is a frequent contributor to industry publications and events, as well as working as a consultant and a member of the Board of Advisors of C2 Pharma.

He joins existing members Dr Uwe Böhlke, Joachim Roeser, and Dr Jürgen Sackhoff.

"We are thrilled to expand our advisory board and align to gain their insight as we grow into a premier ophthalmic and niche active pharmaceutical ingredient (API) supplier with a unique virtual manufacturing model," said Andrew Badrot, CEO of C2 Pharma.

The announcement follows a recent expansion of the company’s API product portfolio with successful validation of Homatropine Hydrobromide and additions to the Digoxin API offering. Further R&D development and tech transfers are in process and are expected to be announced later this year.